About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Change of Company Name and ASX Code

May 24, 2019August 28, 2019

Click here to read more

Post navigation

2019 Annual General Meeting Results

Ashland Purchases Manufacturing Rights for VitalET and TPM

Related Posts

Landmark Agreement with Perrigo

December 20, 2022December 20, 2022

Phosphagenics Restructures

October 12, 2015

Quarterly Activities Report and 4C to 31 March 2022

April 29, 2022April 29, 2022

Recent Posts

Research report | RaaS Watchlist: Waking the Sleeping Giant
August 26, 2025
Media | Avecho featured on 9 News
June 23, 2025
New Sites Commence Recruitment For Phase III Clinical Trial
May 20, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.